Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations.

Agier V, Oliviero P, Lainé J, L'Hermitte-Stead C, Girard S, Fillaut S, Jardel C, Bouillaud F, Bulteau AL, Lombès A.

Biochim Biophys Acta. 2012 Oct;1822(10):1570-80. doi: 10.1016/j.bbadis.2012.07.002.

2.

OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.

Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V.

Brain. 2008 Feb;131(Pt 2):352-67. doi: 10.1093/brain/awm335.

PMID:
18222991
3.

Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.

Olichon A, Landes T, Arnauné-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C, Amati-Bonneau P, Bonneau D, Reynier P, Lenaers G, Belenguer P.

J Cell Physiol. 2007 May;211(2):423-30.

PMID:
17167772
4.

Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.

Mayorov VI, Lowrey AJ, Biousse V, Newman NJ, Cline SD, Brown MD.

BMC Biochem. 2008 Sep 10;9:22. doi: 10.1186/1471-2091-9-22.

5.

Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.

Van Bergen NJ, Crowston JG, Kearns LS, Staffieri SE, Hewitt AW, Cohn AC, Mackey DA, Trounce IA.

PLoS One. 2011;6(6):e21347. doi: 10.1371/journal.pone.0021347.

6.

OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L.

Cell. 2006 Jul 14;126(1):177-89.

8.

A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.

Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, Lindsey JD, Wissinger B, Ellisman MH, Weinreb RN, Perkins GA, Ju WK.

Cell Death Dis. 2011 Dec 8;2:e240. doi: 10.1038/cddis.2011.117.

9.

Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations.

Kao SH, Yen MY, Wang AG, Yeh YL, Lin AL.

Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2269-78. doi: 10.1167/iovs.14-16288.

PMID:
25744979
10.

Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity.

Kushnareva YE, Gerencser AA, Bossy B, Ju WK, White AD, Waggoner J, Ellisman MH, Perkins G, Bossy-Wetzel E.

Cell Death Differ. 2013 Feb;20(2):353-65. doi: 10.1038/cdd.2012.128.

11.

Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.

Brooks C, Cho SG, Wang CY, Yang T, Dong Z.

Am J Physiol Cell Physiol. 2011 Mar;300(3):C447-55. doi: 10.1152/ajpcell.00402.2010.

12.

Histone deacetylase inhibitors induce mitochondrial elongation.

Lee JS, Yoon YG, Yoo SH, Jeong NY, Jeong SH, Lee SY, Jung DI, Jeong SY, Yoo YH.

J Cell Physiol. 2012 Jul;227(7):2856-69. doi: 10.1002/jcp.23027.

PMID:
21928346
13.

Loss of Yme1L perturbates mitochondrial dynamics.

Ruan Y, Li H, Zhang K, Jian F, Tang J, Song Z.

Cell Death Dis. 2013 Oct 31;4:e896. doi: 10.1038/cddis.2013.414.

14.

Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.

Lodi R, Tonon C, Valentino ML, Manners D, Testa C, Malucelli E, La Morgia C, Barboni P, Carbonelli M, Schimpf S, Wissinger B, Zeviani M, Baruzzi A, Liguori R, Barbiroli B, Carelli V.

Arch Neurol. 2011 Jan;68(1):67-73. doi: 10.1001/archneurol.2010.228.

PMID:
20837821
15.

Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.

Formichi P, Radi E, Giorgi E, Gallus GN, Brunetti J, Battisti C, Rufa A, Dotti MT, Franceschini R, Bracci L, Federico A.

J Neurol Sci. 2015 Apr 15;351(1-2):99-108. doi: 10.1016/j.jns.2015.02.047.

PMID:
25796301
16.

Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.

Davies VJ, Hollins AJ, Piechota MJ, Yip W, Davies JR, White KE, Nicols PP, Boulton ME, Votruba M.

Hum Mol Genet. 2007 Jun 1;16(11):1307-18.

PMID:
17428816
17.

Loss of Drp1 function alters OPA1 processing and changes mitochondrial membrane organization.

Möpert K, Hajek P, Frank S, Chen C, Kaufmann J, Santel A.

Exp Cell Res. 2009 Aug 1;315(13):2165-80. doi: 10.1016/j.yexcr.2009.04.016.

PMID:
19409380
18.

Characterization of OPA1 isoforms isolated from mouse tissues.

Akepati VR, Müller EC, Otto A, Strauss HM, Portwich M, Alexander C.

J Neurochem. 2008 Jul;106(1):372-83. doi: 10.1111/j.1471-4159.2008.05401.x.

19.

OPA1-associated disorders: phenotypes and pathophysiology.

Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferré M, Guillet V, Gueguen N, Loiseau D, de Crescenzo MA, Verny C, Procaccio V, Lenaers G, Reynier P.

Int J Biochem Cell Biol. 2009 Oct;41(10):1855-65. doi: 10.1016/j.biocel.2009.04.012. Review.

PMID:
19389487
20.

Optic atrophy 1-dependent mitochondrial remodeling controls steroidogenesis in trophoblasts.

Wasilewski M, Semenzato M, Rafelski SM, Robbins J, Bakardjiev AI, Scorrano L.

Curr Biol. 2012 Jul 10;22(13):1228-34. doi: 10.1016/j.cub.2012.04.054.

Supplemental Content

Support Center